Duration of treatment: 10 days
Sponsors
Prinston Pharmaceutical Inc, Intas Pharmaceuticals Limited
Conditions
Health Condition 1: F209- Schizophrenia, unspecified
Unknown Phase
A bioequivalence study of clozapine tablet 100 mg twice daily (test drug) with Clozaril® 100 mg tablets twice daily (reference drug, Novartis pharmaceuticals corporation, USA) in adult schizophrenic patients under fasting conditions.
Active, not recruitingCTRI/2016/07/007065
Target: 38Updated: 2021-11-24
A Study of Clozapine Extended Release Capsule 200 mg with Clozaril® 100 mg Tablets in Adult Schizophrenic Patients.
Active, not recruitingCTRI/2019/12/022239
Target: 136Updated: 2021-11-24